자동 면역조직화학 염색 기기 시장 보고서(2026년)
Automatic Immunohistochemical Staining Instrument Global Market Report 2026
상품코드 : 1939313
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,629,000
PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,583,000
PDF & Excel (Site License) help
PDF & Excel 보고서를 동일 기업의 동일 사업장 내의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,536,000
PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

자동 면역조직화학 염색 기기 시장 규모는 최근 현저한 성장을 달성하고 있습니다. 2025년 13억 달러에서 2026년에는 14억 달러로, CAGR 7.1%로 확대가 전망되고 있습니다. 지난 수년간의 성장세는 암 진단 검사 건수 증가, 병리검사실 인프라 확충, 질병 진단에서 면역조직화학에 대한 의존도 증가, 자동화 검사기기의 보급 확대, 재현성 있는 진단 결과에 대한 수요 증가 등이 주요 요인으로 꼽힙니다.

자동 면역조직화학 염색 기기 시장 규모는 향후 수년간 견고한 성장이 전망됩니다. 2030년에는 18억 3,000만 달러에 달하며, CAGR은 7.0%에 달할 전망입니다. 예측 기간 중 성장 요인으로는 정밀 종양학 진단의 채택 확대, 디지털 병리 플랫폼에 대한 투자 증가, 실험실 자동화에 대한 수요 증가, 동반 진단 개발 확대, 맞춤형 의료 접근 방식에 대한 집중도 강화 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 완전 자동화 IHC 염색 시스템 도입 확대, 고처리량 진단 워크플로우에 대한 수요 증가, 디지털 병리와의 호환성 강화, 표준화 및 재현성 있는 염색 프로토콜 보급, 검사실 워크플로우 효율화에 대한 집중도 강화 등을 들 수 있습니다.

만성질환의 유병률 증가는 자동 면역조직화학염색장치 시장의 성장을 촉진할 것으로 예측됩니다. 만성질환은 보통 서서히 진행되어 지속적인 관리가 필요한 장기적인 병태를 말합니다. 당뇨병, 심장병, 고혈압, 관절염, 만성 호흡기 질환, 암, 비만 등이 이에 해당합니다. 만성질환 증가는 생활습관의 변화, 부적절한 식습관, 운동 부족과 관련이 있으며, 이는 장기적인 건강 문제의 요인이 되고 있습니다. 자동 면역조직화학염색 장비는 정밀하고 효율적인 조직 분석을 제공하여 진단 능력을 향상시키고, 만성질환의 검출에 필수적인 역할을 합니다. 이 장비들은 신속한 자동 염색 과정을 통해 수작업을 줄이고, 진단 정확도를 높이며, 질병을 조기에 발견할 수 있게 해줍니다. 예를 들어 2024년 6월 영국 국민보건서비스(NHS)가 발표한 자료에 따르면 2023년 일반의(GP)에 등록된 3,615,330명이 비당뇨병성 고혈당 또는 당뇨병 예비군으로 진단을 받았습니다. 이는 2022년 306만 5,825건 대비 18% 증가한 수치입니다. 따라서 만성질환의 유병률 증가가 자동 면역조직화학염색장치 시장의 확대를 견인하고 있습니다.

자동 면역조직화학염색장치 시장의 기업은 조직 분석의 정확성, 효율성, 범용성을 높이는 동시에 비용 절감과 재현성 향상을 위해 항체 대체 시약 등 혁신적인 솔루션 개발에 주력하고 있습니다. 항체 대체 시약은 압타머, 아파머, 항체 모방체 등 표적 항원에 특이적으로 결합할 수 있는 비항체 분자로, 연구, 진단, 치료 용도로 기존 항체를 대체하는 형태로 사용됩니다. 예를 들어 2023년 3월 영국에 본사를 둔 생명공학 기업 Aptamer Group plc는 자동 면역조직화학(IHC) 워크플로우를 위한 새로운 시약 솔루션인 'Optimer-Fc'를 발표했습니다. Optimer-Fc는 면역조직화학의 혁신적인 항체 대체제로서 표적 검출 능력을 확장하고 분석의 선택성을 높입니다. 자동화된 IHC 워크플로우에 완벽하게 통합되어 기존 바이오마커와 신규 바이오마커를 모두 정확하게 식별할 수 있습니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 용도 산업의 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장의 세계 TAM(Total Addressable Market)

제9장 시장 세분화

제10장 지역별·국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 대기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 합병과 인수

제40장 시장의 잠재력이 높은 국가, 부문, 전략

제41장 부록

KSA
영문 목차

영문목차

An automatic immunohistochemical staining instrument is a laboratory device designed to automate the staining of tissue samples for detecting specific proteins or antigens. Its main function is to improve the accuracy, consistency, and efficiency of immunohistochemistry (IHC) tests, which are vital for diagnosing diseases such as cancer by visualizing molecular markers in tissue sections.

The main product types include fully automated stainers, semi-automated stainers, and manual stainers. Fully automated stainers are advanced instruments that perform immunohistochemical or histological staining with minimal human input. The technologies used include slide staining, tissue staining, and fluorescent staining. Consumables involved in the process include antibodies, staining kits, slides, and coverslips. Applications cover oncology, cardiovascular diseases, neurological disorders, and infectious diseases. Key end-users include hospitals, diagnostic laboratories, academic institutions, and research laboratories.

Tariffs are impacting the automatic immunohistochemical staining instrument market by increasing costs of imported precision mechanical components, optical systems, electronic control units, and specialized reagents used in automated stainers. Diagnostic laboratories and hospitals in North America and Europe are most affected due to dependence on imported laboratory equipment, while Asia-Pacific faces pricing pressure on export-oriented instrument manufacturing. These tariffs are raising capital expenditure for pathology labs and slowing equipment replacement cycles. However, they are also encouraging localized manufacturing, regional assembly of diagnostic instruments, and stronger domestic supply chains for critical laboratory technologies.

The automatic immunohistochemical staining instrument market research report is one of a series of new reports from The Business Research Company that provides automatic immunohistochemical staining instrument market statistics, including automatic immunohistochemical staining instrument industry global market size, regional shares, competitors with a automatic immunohistochemical staining instrument market share, detailed automatic immunohistochemical staining instrument market segments, market trends and opportunities, and any further data you may need to thrive in the automatic immunohistochemical staining instrument industry. This automatic immunohistochemical staining instrument market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The automatic immunohistochemical staining instrument market size has grown strongly in recent years. It will grow from $1.3 billion in 2025 to $1.4 billion in 2026 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to rising cancer diagnostic testing volumes, expansion of pathology laboratory infrastructure, increased reliance on immunohistochemistry in disease diagnosis, growing availability of automated laboratory instruments, rising demand for reproducible diagnostic results.

The automatic immunohistochemical staining instrument market size is expected to see strong growth in the next few years. It will grow to $1.83 billion in 2030 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to increasing adoption of precision oncology diagnostics, growing investments in digital pathology platforms, rising demand for laboratory automation, expansion of companion diagnostics development, increasing focus on personalized medicine approaches. Major trends in the forecast period include increasing adoption of fully automated ihc staining systems, rising demand for high-throughput diagnostic workflows, growing integration of digital pathology compatibility, expansion of standardized and reproducible staining protocols, enhanced focus on workflow efficiency in laboratories.

The increasing prevalence of chronic diseases is expected to drive the growth of the automatic immunohistochemical staining instrument market. Chronic diseases refer to long-term medical conditions that typically progress gradually and require continuous management. These include diabetes, heart disease, hypertension, arthritis, chronic respiratory diseases, cancer, and obesity. The rise in chronic diseases is linked to lifestyle changes, poor diet, and insufficient physical activity, all contributing to long-term health complications. Automatic immunohistochemical staining instruments improve diagnostic capabilities by offering precise and efficient tissue analysis, making them crucial for detecting chronic diseases. These instruments reduce manual labor with fast, automated staining processes, improving diagnostic accuracy and enabling earlier disease detection. For example, in June 2024, the National Health Service (NHS) in the UK reported that 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, an 18% increase from 3,065,825 cases in 2022. Therefore, the growing prevalence of chronic diseases is driving the expansion of the automatic immunohistochemical staining instrument market.

Companies in the automatic immunohistochemical staining instrument market are focusing on developing innovative solutions, such as antibody alternative reagents, to enhance the accuracy, efficiency, and versatility of tissue analysis while reducing costs and improving reproducibility. An antibody alternative reagent is a non-antibody molecule, such as an aptamer, affirmer, or antibody mimetic, that can specifically bind to target antigens and be used instead of traditional antibodies in research, diagnostic, or therapeutic applications. For example, in March 2023, Aptamer Group plc, a U.K.-based biotechnology company, launched Optimer-Fc, a new reagent solution for automated immunohistochemistry (IHC) workflows. Optimer-Fc offers an innovative antibody alternative for immunohistochemistry, expanding target detection capabilities and enhancing assay selectivity. It integrates seamlessly into automated IHC workflows, allowing for the accurate identification of both established and novel biomarkers.

In July 2023, Bio-Techne Corporation, a U.S.-based biotechnology and life sciences company, acquired Lunaphore Technologies SA for $170.1 million. This acquisition strengthens Bio-Techne's position in spatial biology and automated IHC by integrating Lunaphore's microfluidic staining platforms, enhancing high-throughput tissue analysis and precision research. Lunaphore Technologies SA is a Switzerland-based biotech company specializing in automated immunohistochemistry (IHC) and immunofluorescence (IF) staining instruments.

Major companies operating in the automatic immunohistochemical staining instrument market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Agilent Technologies, Leica Biosystems, Sakura Finetek, Olympus Corporation, Biocare Medical, Celnovte Biotechnology Co. Ltd., BioGenex Laboratories, Diagnostic BioSystems, ADS Biotec, Fuzhou Maixin Biotech Co. Ltd., Shenzhen Dartmon Biotechnology Co. Ltd., Ventana Medical Systems, Dako (Agilent Pathology), Nichirei Biosciences Inc., Abcam plc, Bio-Rad Laboratories, Milestone Medical, Medite GmbH

North America was the largest region in the automatic immunohistochemical staining instrument market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automatic immunohistochemical staining instrument market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the automatic immunohistochemical staining instrument market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The automatic immunohistochemical staining instrument market consists of sales of slide holders, reagent dispensers, detection systems, and associated consumables such as antibodies, detection kits, and chromogens used in the immunohistochemical staining process. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Automatic Immunohistochemical Staining Instrument Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses automatic immunohistochemical staining instrument market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for automatic immunohistochemical staining instrument ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The automatic immunohistochemical staining instrument market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

2. Automatic Immunohistochemical Staining Instrument Market Characteristics

3. Automatic Immunohistochemical Staining Instrument Market Supply Chain Analysis

4. Global Automatic Immunohistochemical Staining Instrument Market Trends And Strategies

5. Automatic Immunohistochemical Staining Instrument Market Analysis Of End Use Industries

6. Automatic Immunohistochemical Staining Instrument Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Automatic Immunohistochemical Staining Instrument Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

8. Global Automatic Immunohistochemical Staining Instrument Total Addressable Market (TAM) Analysis for the Market

9. Automatic Immunohistochemical Staining Instrument Market Segmentation

10. Automatic Immunohistochemical Staining Instrument Market Regional And Country Analysis

11. Asia-Pacific Automatic Immunohistochemical Staining Instrument Market

12. China Automatic Immunohistochemical Staining Instrument Market

13. India Automatic Immunohistochemical Staining Instrument Market

14. Japan Automatic Immunohistochemical Staining Instrument Market

15. Australia Automatic Immunohistochemical Staining Instrument Market

16. Indonesia Automatic Immunohistochemical Staining Instrument Market

17. South Korea Automatic Immunohistochemical Staining Instrument Market

18. Taiwan Automatic Immunohistochemical Staining Instrument Market

19. South East Asia Automatic Immunohistochemical Staining Instrument Market

20. Western Europe Automatic Immunohistochemical Staining Instrument Market

21. UK Automatic Immunohistochemical Staining Instrument Market

22. Germany Automatic Immunohistochemical Staining Instrument Market

23. France Automatic Immunohistochemical Staining Instrument Market

24. Italy Automatic Immunohistochemical Staining Instrument Market

25. Spain Automatic Immunohistochemical Staining Instrument Market

26. Eastern Europe Automatic Immunohistochemical Staining Instrument Market

27. Russia Automatic Immunohistochemical Staining Instrument Market

28. North America Automatic Immunohistochemical Staining Instrument Market

29. USA Automatic Immunohistochemical Staining Instrument Market

30. Canada Automatic Immunohistochemical Staining Instrument Market

31. South America Automatic Immunohistochemical Staining Instrument Market

32. Brazil Automatic Immunohistochemical Staining Instrument Market

33. Middle East Automatic Immunohistochemical Staining Instrument Market

34. Africa Automatic Immunohistochemical Staining Instrument Market

35. Automatic Immunohistochemical Staining Instrument Market Regulatory and Investment Landscape

36. Automatic Immunohistochemical Staining Instrument Market Competitive Landscape And Company Profiles

37. Automatic Immunohistochemical Staining Instrument Market Other Major And Innovative Companies

38. Global Automatic Immunohistochemical Staining Instrument Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Automatic Immunohistochemical Staining Instrument Market

40. Automatic Immunohistochemical Staining Instrument Market High Potential Countries, Segments and Strategies

41. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기